ArticleThe American economic review2018
Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage.
Article in The American economic review, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and determinants of financial toxicity in patients with colorectal cancer: a systematic review and meta-analysis.International journal for equity in health · 2026Pooled it
- Does Medicare Advantage funding disparity affect managed care insurers' profitability? Evidence from Puerto Rico.Health affairs scholar · 2026Article
- Double Bonuses Increased MA Spending In Puerto Rico By $865 Million But Did Not Achieve Plan Improvement Goals.Health affairs (Project Hope) · 2026Article
- Increased payments to Medicare Advantage plans for dually eligible beneficiaries.The American journal of managed care · 2026Article
- Medicare Advantage Enrollment Increased Disproportionately In Chain-Owned Dialysis Facilities After The Cures Act.Health affairs (Project Hope) · 2025Article
- Do MA plans follow incentives to attract enrollee groups with new supplemental benefits?Health affairs scholar · 2025Article
- Private Medicare plans' responses to benchmark changes and competition before and after the Affordable Care Act's payment cuts.Health services research · 2025Article
- No Association Between Medicare Advantage Providers' Network Restrictiveness and Star Rating Between 2013 and 2017: An Observational Study.Journal of general internal medicine · 2025Observational
- Medicare Advantage: National Carriers Expand Market Share While Regional Carriers Without Affiliation Decline, 2012-23.Health affairs (Project Hope) · 2024Article
- A framework for ex-ante evaluation of the potential effects of risk equalization and risk sharing in health insurance markets with regulated competition.Health economics review · 2024Review
- Medicare-Covered Services Near the End of Life in Medicare Advantage vs Traditional Medicare.JAMA health forum · 2024Article
- Is there an advantage? Considerations for researchers studying the effects of the type of Medicare coverage.Health services research · 2024Review
- Association Between the Medicare Advantage Quartile Adjustment System and Plan Behavior and Enrollment.JAMA health forum · 2024Article
- What Difference Does a Health Plan Make? Evidence from Random Plan Assignment in Medicaid.American economic journal. Applied economics · 2023Article
- Growth of Medicare Advantage After Plan Payment Reductions.JAMA health forum · 2023Article
- Effects of Medicare Advantage on preventive care use and health behavior.Health services research · 2023Article
- Comparison of Care Quality Metrics in 2-Sided Risk Medicare Advantage vs Fee-for-Service Medicare Programs.JAMA network open · 2022Article
- Healthcare Rationing in Public Insurance Programs: Evidence from Medicaid.American economic journal. Economic policy · 2022Article
- Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness.Health services research · 2022Article
- Effects of establishing a financing scheme for outpatient care on inpatient services: empirical evidence from a quasi-experiment in China.The European journal of health economics : HEPAC : health economics in prevention and care · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A central question in the debate over privatized Medicare is whether increased government payments to private Medicare Advantage (MA) plans generate lower premiums for consumers or higher profits for producers. Using difference‑in‑differences variation brought about by a sharp legislative change, we find that MA insurers pass through 45 percent of increased payments in lower premiums and an additional 9 percent in more generous benefits. We show that advantageous selection into MA cannot explain this incomplete pass‑through. Instead, our evidence suggests that market power is important, with premium pass‑through rates of 13 percent in the least competitive markets and 74 percent in the most competitive.
Indexed as
Identifiers
30091862PMC10782851What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.